Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1968 2
1974 2
1976 1
1977 1
1980 1
1982 2
1984 2
1985 2
1989 3
1990 3
1991 2
1992 3
1993 1
1994 4
1995 6
1996 7
1997 1
1998 5
1999 8
2000 5
2001 8
2002 4
2003 6
2004 7
2005 6
2006 10
2007 8
2008 7
2009 9
2010 5
2011 11
2012 17
2013 6
2014 3
2015 6
2016 10
2017 11
2018 14
2019 17
2020 6
2021 7
2022 7
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Ovarian dysgenesis 5"
Page 1
Diagnosis and Management of Infertility: A Review.
Carson SA, Kallen AN. Carson SA, et al. JAMA. 2021 Jul 6;326(1):65-76. doi: 10.1001/jama.2021.4788. JAMA. 2021. PMID: 34228062 Free PMC article. Review.
Clomiphene citrate, aromatase inhibitors such as letrozole, and gonadotropins are used to induce ovulation or for ovarian stimulation during in vitro fertilization (IVF) cycles. Adverse effects of gonadotropins include multiple pregnancy (up to 36% of cycles, depending on …
Clomiphene citrate, aromatase inhibitors such as letrozole, and gonadotropins are used to induce ovulation or for ovarian stimulation …
Polycystic ovary syndrome.
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Azziz R, et al. Nat Rev Dis Primers. 2016 Aug 11;2:16057. doi: 10.1038/nrdp.2016.57. Nat Rev Dis Primers. 2016. PMID: 27510637 Review.
Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide. The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology (PCOM) - with excessive androgen production by the ovaries being a key …
Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide. The condition is characterized by hyperandroge …
Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.
Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL, Michos ED. Guan C, et al. Fertil Steril. 2022 May;117(5):924-935. doi: 10.1016/j.fertnstert.2022.03.009. Fertil Steril. 2022. PMID: 35512976 Free article. Review.
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age and is hallmarked by hyperandrogenism, oligo-ovulation, and polycystic ovarian morphology. Polycystic ovary syndrome, particularly the hyperandrogenism phenotype, is asso …
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age and is hallmarked by hyperandrogenism …
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES). Goodman NF, et al. Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
This document, produced by the collaboration of the American Association of Clinical Endocrinologists (AACE) and the Androgen Excess and PCOS Society (AES) aims to highlight the most important clinical issues confronting physicians and their patients with PCOS. ...G …
This document, produced by the collaboration of the American Association of Clinical Endocrinologists (AACE) and the Androgen Excess …
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L, Marzullo P, Muscogiuri G, Di Somma C, Scacchi M, Orio F, Aimaretti G, Colao A, Savastano S. Barrea L, et al. Nutr Res Rev. 2018 Dec;31(2):291-301. doi: 10.1017/S0954422418000136. Epub 2018 Jul 23. Nutr Res Rev. 2018. PMID: 30033891 Review.
The role of insulin in PCOS is pivotal both in regulating the activity of ovarian and liver enzymes, respectively involved in androgen production and in triggering low-grade inflammation usually reported to be associated with an insulin resistance, dyslipidaemia and cardio …
The role of insulin in PCOS is pivotal both in regulating the activity of ovarian and liver enzymes, respectively involved in androge …
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society. Goodman NF, et al. Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
This document, produced by the collaboration of the American Association of Clinical Endocrinologists and the Androgen Excess Society aims to highlight the most important clinical issues confronting physicians and their patients with PCOS. ...Women should be counsel …
This document, produced by the collaboration of the American Association of Clinical Endocrinologists and the Androgen Excess Society …
Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.
Fraser GL, Obermayer-Pietsch B, Laven J, Griesinger G, Pintiaux A, Timmerman D, Fauser BCJM, Lademacher C, Combalbert J, Hoveyda HR, Ramael S. Fraser GL, et al. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3519-e3532. doi: 10.1210/clinem/dgab320. J Clin Endocrinol Metab. 2021. PMID: 34000049 Free PMC article. Clinical Trial.
The study was conducted at 5 European clinical centers. Women with PCOS participated in the study. ...The primary efficacy end point was change in total testosterone. Gonadotropins, ovarian hormones, safety and tolerability were also assessed. RESULTS: Sevent …
The study was conducted at 5 European clinical centers. Women with PCOS participated in the study. ...The primary efficacy end …
Malignant ovarian germ-cell tumours.
Low JJ, Ilancheran A, Ng JS. Low JJ, et al. Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):347-55. doi: 10.1016/j.bpobgyn.2012.01.002. Epub 2012 Feb 1. Best Pract Res Clin Obstet Gynaecol. 2012. PMID: 22301054 Free article. Review.
Malignant ovarian germ-cell tumours account for about 5% of all ovarian malignancies and typically present in the teenage years. ...Bleomycin, etoposide and cisplatin combination chemotherapy is regarded as the gold standard for adjuvant therapy. Studies eval …
Malignant ovarian germ-cell tumours account for about 5% of all ovarian malignancies and typically present in the teena …
Hair loss in women.
Camacho-Martínez FM. Camacho-Martínez FM. Semin Cutan Med Surg. 2009 Mar;28(1):19-32. doi: 10.1016/j.sder.2009.01.001. Semin Cutan Med Surg. 2009. PMID: 19341939 Review.
The diagnosis of FPHL is made by clinical history, clinical examination, wash test, dermoscopy, trichoscan, trichograms and laboratory test, especially androgenic determinations. ...Antiandrogens therapy includes cyproterone acetate, drospirenone, spironolactone, fl …
The diagnosis of FPHL is made by clinical history, clinical examination, wash test, dermoscopy, trichoscan, trichograms and la …
The progestogen-only mini-pill.
Graham S, Fraser IS. Graham S, et al. Contraception. 1982 Oct;26(4):373-88. doi: 10.1016/0010-7824(82)90104-4. Contraception. 1982. PMID: 6759029 Review.
The minipill exerts its antifertility influence at the endometrial, ovarian, tubal ephithelial, follicular, and luteal levels as well as on the cervix and cervical mucus. ...Progestogen may protect against endometrial cancer. No cases of congenital abnormality have …
The minipill exerts its antifertility influence at the endometrial, ovarian, tubal ephithelial, follicular, and luteal levels as well …
235 results